DD270723A5 - Verfahren zur Herstellung von hochreinem Chymopapain - Google Patents
Verfahren zur Herstellung von hochreinem Chymopapain Download PDFInfo
- Publication number
- DD270723A5 DD270723A5 DD31628488A DD31628488A DD270723A5 DD 270723 A5 DD270723 A5 DD 270723A5 DD 31628488 A DD31628488 A DD 31628488A DD 31628488 A DD31628488 A DD 31628488A DD 270723 A5 DD270723 A5 DD 270723A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- chymopapain
- buffer
- preparation
- crude
- reducing agent
- Prior art date
Links
- 108090001069 Chymopapain Proteins 0.000 title claims abstract description 26
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 title claims abstract description 26
- 229960002976 chymopapain Drugs 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 229940088598 enzyme Drugs 0.000 claims abstract description 10
- 239000000872 buffer Substances 0.000 claims abstract description 8
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 8
- 238000005227 gel permeation chromatography Methods 0.000 claims abstract description 8
- 239000006228 supernatant Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 10
- 235000018417 cysteine Nutrition 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 9
- 229920005654 Sephadex Polymers 0.000 claims description 7
- 239000012507 Sephadex™ Substances 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 6
- 239000008351 acetate buffer Substances 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 235000010265 sodium sulphite Nutrition 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 18
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 7
- 229910001626 barium chloride Inorganic materials 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 241000219173 Carica Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 101710097834 Thiol protease Proteins 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- LHFNPUGRSYOPLF-UHFFFAOYSA-N (4-nitrophenyl) 2-(phenylmethoxycarbonylamino)acetate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)CNC(=O)OCC1=CC=CC=C1 LHFNPUGRSYOPLF-UHFFFAOYSA-N 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002196 fr. b Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD31628488A DD270723A5 (de) | 1986-12-08 | 1988-06-01 | Verfahren zur Herstellung von hochreinem Chymopapain |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU865090A HU196624B (en) | 1986-12-08 | 1986-12-08 | Process for producing chymopapain with high specific activity |
| DD31628488A DD270723A5 (de) | 1986-12-08 | 1988-06-01 | Verfahren zur Herstellung von hochreinem Chymopapain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD270723A5 true DD270723A5 (de) | 1989-08-09 |
Family
ID=10969645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD31628488A DD270723A5 (de) | 1986-12-08 | 1988-06-01 | Verfahren zur Herstellung von hochreinem Chymopapain |
Country Status (5)
| Country | Link |
|---|---|
| BG (1) | BG50942A3 (cs) |
| CS (1) | CS271346B2 (cs) |
| CU (1) | CU22158A3 (cs) |
| DD (1) | DD270723A5 (cs) |
| HU (1) | HU196624B (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5468480A (en) * | 1989-04-28 | 1995-11-21 | The Boots Company Plc | Pharmaceutical composition of purified chymopapain |
| CN1320111C (zh) * | 2004-08-09 | 2007-06-06 | 王美岭 | 一种制备木瓜凝乳酶的方法 |
-
1986
- 1986-12-08 HU HU865090A patent/HU196624B/hu not_active IP Right Cessation
-
1988
- 1988-05-18 CU CU8870A patent/CU22158A3/es unknown
- 1988-06-01 CS CS883773A patent/CS271346B2/cs unknown
- 1988-06-01 DD DD31628488A patent/DD270723A5/de not_active IP Right Cessation
- 1988-06-01 BG BG084338A patent/BG50942A3/bg unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5468480A (en) * | 1989-04-28 | 1995-11-21 | The Boots Company Plc | Pharmaceutical composition of purified chymopapain |
| CN1320111C (zh) * | 2004-08-09 | 2007-06-06 | 王美岭 | 一种制备木瓜凝乳酶的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CU22158A3 (es) | 1994-01-31 |
| HU196624B (en) | 1988-12-28 |
| CS271346B2 (en) | 1990-09-12 |
| CS377388A2 (en) | 1989-12-13 |
| BG50942A3 (bg) | 1992-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3885374T2 (de) | Stabile wässerige Thrombinlösung. | |
| DE2734821A1 (de) | Verfahren zur herstellung einer blutgerinnungsfoerdernden praeparation aus menschlichem blutplasma | |
| CH665356A5 (de) | Pharmazeutische formulierung. | |
| DE2440529B2 (de) | Hyaluronidase-Präparat aus menschlicher Plazenta | |
| EP0101063A2 (de) | Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel | |
| DE2459915C3 (de) | Aktive Verbindung des Plasminogen- Typs, Verfahren zu ihrer Reinigung und ihre Verwendung | |
| AT397390B (de) | Verfahren zur spaltung von proteinen | |
| DE1442134C3 (de) | In vivo antikoagulierend wirkendes und defibrinierendes Enzym | |
| DE69126437T2 (de) | Inhibitor der blutplättchen-aggregation | |
| EP0626070B1 (de) | Verfahren zur bestimmung von hirudin und synthetischen trhombininhibitoren | |
| DE3306944C2 (cs) | ||
| DD270723A5 (de) | Verfahren zur Herstellung von hochreinem Chymopapain | |
| DE2047317C3 (de) | Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen | |
| DE2715748C3 (de) | Gereinigte aktive Verbindung des Plasminogen-Typs menschlichen Ursprungs und ihre Verwendung | |
| DE2605576A1 (de) | Verfahren zur herstellung von reinen, proteolytisch aktiven enzymen aus milchsaft von carica papaya | |
| DE1617279C3 (de) | Verfahren zur Herstellung eines die Aspergillopeptidase ARL 1 enthaltenden Präparates aus Aspergillus oryzae und sie enthaltendes Arzneimittel | |
| CH634854A5 (de) | Verfahren zur herstellung organopeptidhaltiger substanzen mit insulinaehnlicher wirksamkeit aus blut oder blutbestandteilen. | |
| DE69012958T2 (de) | Fibrinolytisches Protein und Herstellungsweise dafür. | |
| DE3888404T2 (de) | Verfahren zur Unterdrückung des thermischen Abbaus der Urokinase. | |
| DE3148517A1 (de) | Neues und therapeutisch wirksames enzym | |
| DE2855698A1 (de) | Verfahren zur herstellung eines urokinase mit einem molekulargewicht von 54 000 + 10 000 enthaltenden praeparats und seine verwendung als fibrinolytikum und thrombolytikum | |
| DE2024251C3 (de) | Verfahren zur Isolierung eines fibrinolytischen Enzyms und dieses Enzym | |
| Finlayson et al. | STUDIES ON WHEAT PLANTS USING CARBON-14 COMPOUNDS: XVI. FRACTIONATION OF A PERFORMIC ACID OXIDIZED PROTEIN | |
| DD143629A5 (de) | Reagenz zum nachweis von krebs beim menschen | |
| Seino et al. | The possible role of the duodenum in an entero-PP axis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |